166 related articles for article (PubMed ID: 26847530)
21. Targeting of CDKN1B by miR-222-3p may contribute to the development of intervertebral disc degeneration.
Liu J; Yu J; Jiang W; He M; Zhao J
FEBS Open Bio; 2019 Apr; 9(4):728-735. PubMed ID: 30984546
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-222-3p participates in the development of oral squamous cell carcinoma by targeting CDKN1B.
Yang K; Chen Y; Cui Z; Chen H; Yang L; Zhao J; Luo F; Man S; Zhao J; Jin L
J Oral Pathol Med; 2020 Aug; 49(7):621-629. PubMed ID: 31841247
[TBL] [Abstract][Full Text] [Related]
23. miR-148a promoted cell proliferation by targeting p27 in gastric cancer cells.
Guo SL; Peng Z; Yang X; Fan KJ; Ye H; Li ZH; Wang Y; Xu XL; Li J; Wang YL; Teng Y; Yang X
Int J Biol Sci; 2011 May; 7(5):567-74. PubMed ID: 21552422
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-146b acts as a potential tumor suppressor in human prostate cancer.
Ding HY; Qian WQ; Xu J
J BUON; 2016; 21(2):434-43. PubMed ID: 27273955
[TBL] [Abstract][Full Text] [Related]
25. Upregulation of MircoRNA-370 induces proliferation in human prostate cancer cells by downregulating the transcription factor FOXO1.
Wu Z; Sun H; Zeng W; He J; Mao X
PLoS One; 2012; 7(9):e45825. PubMed ID: 23029264
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-494-3p targets CXCR4 to suppress the proliferation, invasion, and migration of prostate cancer.
Shen PF; Chen XQ; Liao YC; Chen N; Zhou Q; Wei Q; Li X; Wang J; Zeng H
Prostate; 2014 May; 74(7):756-67. PubMed ID: 24644030
[TBL] [Abstract][Full Text] [Related]
27. LncRNA SNHG6 is Associated with Poor Prognosis of Gastric Cancer and Promotes Cell Proliferation and EMT through Epigenetically Silencing p27 and Sponging miR-101-3p.
Yan K; Tian J; Shi W; Xia H; Zhu Y
Cell Physiol Biochem; 2017; 42(3):999-1012. PubMed ID: 28683446
[TBL] [Abstract][Full Text] [Related]
28. circCRKL suppresses the progression of prostate cancer cells by regulating the miR-141/KLF5 axis.
Nan C; Wang Y; Yang S; Chen Y
Pathol Res Pract; 2020 Nov; 216(11):153182. PubMed ID: 32919302
[TBL] [Abstract][Full Text] [Related]
29. Tumor-Secreted Exosomal miR-222 Promotes Tumor Progression via Regulating P27 Expression and Re-Localization in Pancreatic Cancer.
Li Z; Tao Y; Wang X; Jiang P; Li J; Peng M; Zhang X; Chen K; Liu H; Zhen P; Zhu J; Liu X; Liu X
Cell Physiol Biochem; 2018; 51(2):610-629. PubMed ID: 30458449
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-214 targets PTK6 to inhibit tumorigenic potential and increase drug sensitivity of prostate cancer cells.
Cagle P; Niture S; Srivastava A; Ramalinga M; Aqeel R; Rios-Colon L; Chimeh U; Suy S; Collins SP; Dahiya R; Kumar D
Sci Rep; 2019 Jul; 9(1):9776. PubMed ID: 31278310
[TBL] [Abstract][Full Text] [Related]
31. microRNA-1246 Is an Exosomal Biomarker for Aggressive Prostate Cancer.
Bhagirath D; Yang TL; Bucay N; Sekhon K; Majid S; Shahryari V; Dahiya R; Tanaka Y; Saini S
Cancer Res; 2018 Apr; 78(7):1833-1844. PubMed ID: 29437039
[TBL] [Abstract][Full Text] [Related]
32. Lack of prognostic significance of p16 and p27 after radical prostatectomy in hormone-naïve prostate cancer.
Vlachostergios PJ; Karasavvidou F; Kakkas G; Kapatou K; Gioulbasanis I; Daliani DD; Moutzouris G; Papandreou CN
J Negat Results Biomed; 2012 Jan; 11(1):2. PubMed ID: 22221586
[TBL] [Abstract][Full Text] [Related]
33. miR-564 inhibited metastasis and proliferation of prostate cancer by targeting MLLT3.
Meng FJ; Meng FM; Wu HX; Cao XF
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4828-4834. PubMed ID: 29164580
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-195-5p, a new regulator of Fra-1, suppresses the migration and invasion of prostate cancer cells.
Wu J; Ji A; Wang X; Zhu Y; Yu Y; Lin Y; Liu Y; Li S; Liang Z; Xu X; Zheng X; Xie L
J Transl Med; 2015 Sep; 13():289. PubMed ID: 26337460
[TBL] [Abstract][Full Text] [Related]
35. Expression of Tripartite Motif-Containing Proteactiin 11 (TRIM11) is Associated with the Progression of Human Prostate Cancer and is Downregulated by MicroRNA-5193.
Pan Y; Zhang R; Chen H; Chen W; Wu K; Lv J
Med Sci Monit; 2019 Jan; 25():98-106. PubMed ID: 30608062
[TBL] [Abstract][Full Text] [Related]
36. miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways.
Majid S; Dar AA; Saini S; Shahryari V; Arora S; Zaman MS; Chang I; Yamamura S; Tanaka Y; Chiyomaru T; Deng G; Dahiya R
Clin Cancer Res; 2013 Jan; 19(1):73-84. PubMed ID: 23147995
[TBL] [Abstract][Full Text] [Related]
37. microRNA-200b and microRNA-200c promote colorectal cancer cell proliferation via targeting the reversion-inducing cysteine-rich protein with Kazal motifs.
Pan Y; Liang H; Chen W; Zhang H; Wang N; Wang F; Zhang S; Liu Y; Zhao C; Yan X; Zhang J; Zhang CY; Gu H; Zen K; Chen X
RNA Biol; 2015; 12(3):276-89. PubMed ID: 25826661
[TBL] [Abstract][Full Text] [Related]
38. microRNA-150 promotes cervical cancer cell growth and survival by targeting FOXO4.
Li J; Hu L; Tian C; Lu F; Wu J; Liu L
BMC Mol Biol; 2015 Dec; 16():24. PubMed ID: 26715362
[TBL] [Abstract][Full Text] [Related]
39. miR-221 promotes tumorigenesis in human triple negative breast cancer cells.
Nassirpour R; Mehta PP; Baxi SM; Yin MJ
PLoS One; 2013; 8(4):e62170. PubMed ID: 23637992
[TBL] [Abstract][Full Text] [Related]
40. MiR-196a is upregulated in gastric cancer and promotes cell proliferation by downregulating p27(kip1).
Sun M; Liu XH; Li JH; Yang JS; Zhang EB; Yin DD; Liu ZL; Zhou J; Ding Y; Li SQ; Wang ZX; Cao XF; De W
Mol Cancer Ther; 2012 Apr; 11(4):842-52. PubMed ID: 22343731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
